Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03162536 |
Title | Safety, PK, PD, and Antitumor Activity of ARQ 531 in Hematologic Malignancies |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | ArQule |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Mayo Clinic Hospital ( Site 0140) | Scottsdale | Arizona | 85259 | United States | Details | |
UCLA Hematology & Oncology ( Site 0017) | Los Angeles | California | 90095 | United States | Details | |
Colorado Blood Cancer Institute ( Site 0225) | Denver | Colorado | 80218 | United States | Details | |
University of Michigan ( Site 0018) | Ann Arbor | Michigan | 48109 | United States | Details | |
Mayo Clinic - Rochester ( Site 0138) | Rochester | Minnesota | 58905 | United States | Details | |
Duke Cancer Center ( Site 0067) | Durham | North Carolina | 27710 | United States | Details | |
The Ohio State University Wexner Medical Center ( Site 0056) | Columbus | Ohio | 43210 | United States | Details | |
Tennessee Oncology, PLLC ( Site 0020) | Nashville | Tennessee | 37203 | United States | Details | |
UT Southwestern Medical Center ( Site 0116) | Dallas | Texas | 75390-8562 | United States | Details | |
University of Utah, Huntsman Cancer Institute ( Site 0122) | Salt Lake City | Utah | 84112 | United States | Details |